logo
logo

Renovia Raises $17M In Series C-1 Financing

Apr 19, 2021•over 4 years ago

Amount Raised

$17 Million

Round Type

series c

Boston

Description

Renovia Inc. ("Renovia"), a women-led company that develops digital therapeutics for female pelvic floor disorders, today announced the closing of an additional round of equity funding totaling $17 million. The financing included new investor, Parian Global Management, along with existing Renovia investors, including Perceptive Life Sciences, Longwood Fund, Ascension Ventures and OSF Ventures.

Company Information

Company

Renovia

Location

Boston, Massachusetts, United States

About

Boston-based Renovia Inc. is a women-led company dedicated to improving the lives of women with pelvic floor disorders. Renovia's flagship product, the leva® Digital Therapeutic, offers a novel, effective, first-line treatment for urinary incontinence, an underreported condition affecting 20 million women in the U.S. alone. Renovia's technology enables non-invasive, drug-free treatment via precise visualization of pelvic movement in real time during pelvic floor muscle training, while monitoring usage and progress. For more information about Renovia or the leva Digital Therapeutic, please visit www.renoviainc.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech